Who is sponsoring NCT05954949?

NCT05954949 is sponsored by Jean Christophe Saurin.

What drugs are being tested in NCT05954949?

Interventions in NCT05954949: Adenomas detection rate with the different observation methods.

What condition does NCT05954949 study?

NCT05954949 studies Adenomatous Polyps.

Is NCT05954949 still recruiting?

NCT05954949 is currently status unknown. Last updated 25 September 2023.

Last reviewed 2023-09-25 · How we verify

NCT05954949: DARIAC

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Detection of Ileoanal Pouch/Reservoir Adenomas

Status unknown Last updated 25 September 2023

What this trial tests

trial testing Adenomas detection rate with the different observation methods in Adenomatous Polyps in 40 participants. Status unknown.

Timeline

9 September 2024

Primary endpoint
10 September 2025

11 September 2025

Quick facts

Lead sponsor	Jean Christophe Saurin
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	40
Start date	9 September 2024
Primary completion	10 September 2025
Estimated completion	11 September 2025

Drugs / interventions tested

Adenomas detection rate with the different observation methods

Conditions studied

Adenomatous Polyps — all drugs for Adenomatous Polyps →

Sponsor

Jean Christophe Saurin

Who can join

Adults 18 to 90, any sex, with Adenomatous Polyps. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The detection of adenomas is the basis for the follow-up of patients with familial adenomatous polyposis, after colectomy, with a remnant rectum or an ileal pouch. The optimal method for the adenomas detection is not defined yet. Despite the proven effectiveness of indigo-carmine in different indications dye chromoendoscopy is not used in a consensual way at the international level. The situation of the ileal pouch is specific as adenomas have a usually flat shape and are much more difficult to identify than in the situation of a remnant rectum, even in the situation of \> 5 mm adenomas that should be resected. Our hypothesis is that indigo-carmine can improve adenomas detection, including \> 5 mm adenomas, in patients with a an ileal pouch after colectomy improving the effectiveness of surveillance programs and potentially reducing the risk of cancer in this population.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Adenomatous Polyps

Currently open trials in the same condition.

NCT06961149 — Linked-Color Imaging Versus Indigo Carmine Pump Spraying on the Colorectal Adenoma Detection Rate · NA · recruiting
NCT06220617 — Multi-omics Study for Early Detection of Colorectal Cancer (MOED-CRC) · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05954949 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Jean Christophe Saurin
Last refreshed: 25 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05954949.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing